Kordasiewicz Holly B. 4/A
4/A · IONIS PHARMACEUTICALS INC · Filed Jan 20, 2026
Insider Transaction Report
Form 4/AAmended
Kordasiewicz Holly B.
EVP, Chief Development Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
[F1]2026-01-02+7,500→ 16,600 totalExercise: $79.67From: 2027-01-02Exp: 2036-01-01→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]Grant on 01/02/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Holly Kordasiewicz|2026-01-20